Anebulo Pharmaceuticals, Inc.

ANEB

Anebulo Pharmaceuticals, Inc.

ANEB

Insider Sentiment (TTM):

Last Purchase:2024-12-23Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:22,208,686Shares Outstanding:41,084,731Institutional Ownership Pct.:54.06%

Earnings Market Reaction:

Filing Date:2026-02-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Assets
Cash And Cash Equivalents At Carrying Value	9	10	12	13	15	1	3	5	7	9	11	-
Cash	-	-	-	-	-	-	-	-	-	-	11	14
Assets Current
Assets Current	9	11	12	14	15	2	4	5	7	-	12	-
Grants Receivable	-	-	-	-	0	0	-	-	-	-	-	-
Prepaid Expense Current	0	0	0	1	0	0	0	0	0	1	0	0
Assets Noncurrent
Other Assets Noncurrent	0	0	0	0	0	1	1	1	1	-	-	-
Assets	9	11	12	14	16	2	4	6	8	9	12	14
Liabilities And Stockhold…
Accounts Payable Current	1	1	0	0	0	0	0	0	0	1	1	1
Liabilities Current
Accrued Liabilities Current	1	0	0	0	1	0	0	1	1	0	1	1
Liabilities	1	1	0	1	1	1	0	1	1	1	1	1
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	86	86	86	85	85	69	69	69	69	68	68	68
Stockholders Equity	8	10	12	13	15	2	4	5	6	8	11	13
Retained Earnings Accumulated Deficit	-78	-76	-74	-72	-70	-68	-65	-64	-62	-60	-57	-55
Liabilities And Stockholders Equity	9	11	12	14	16	2	4	6	8	9	12	14
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	2	2	2	2	2	2	2	2	2	2	0	2
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	75	75	75	50	50	50	50	50	40	40	40	40
Common Stock Shares Issued	41	41	41	41	41	26	26	26	26	26	26	26
Shares Outstanding	41	41	41	41	41	26	26	26	26	26	26	26

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.64%	-52.32%	-55.70%	-4.21%	57.89%	-3.16%	-	-	-	-	-	-
2025	-6.77%	6.45%	-0.90%	-19.55%	-23.31%	-13.53%	10.77%	72.31%	192.31%	13.64%	-2.69%	-10.33%
2024	9.91%	13.21%	20.75%	14.34%	7.75%	14.34%	-8.05%	9.75%	-15.25%	6.00%	-14.16%	-24.32%
2023	-	-	-	-	-	-	7.96%	1.08%	-5.63%	-25.00%	-34.45%	-28.96%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Leverage & Debt
Interest Coverage TTM	-30.60	-26.70	-24.14	-19.40	-33.52	-38.77	-54.94	-103.38	-334.90	-	-	-
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-
Per Share Metrics
Diluted EPS TTM	-0.19	-0.21	-0.25	-0.19	-0.28	-0.31	-0.32	-0.36	-0.41	-0.45	-0.47	-0.45
Free Cash Flow Per Share TTM	-0.14	-0.14	-0.19	-0.16	-0.24	-0.27	-0.31	-0.34	-0.37	-0.40	-0.39	-0.34
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	4.06%	6.57%	3.45%	-17.73%	-26.92%	-31.72%	-30.09%	-19.14%	-1.38%	47.15%	71.89%	-72.74%
EPS Growth (1Y)	-30.56%	-32.73%	-21.01%	-48.07%	-31.25%	-32.51%	-32.12%	-20.07%	-1.97%	34.42%	60.03%	-75.18%
Valuation Metrics
P/E TTM	-5.20	-12.17	-5.74	-6.95	-6.01	-6.32	-8.60	-7.96	-5.95	-6.75	-5.02	-6.43
P/B TTM	5.23	10.55	4.18	3.97	3.08	26.36	18.49	14.93	9.62	9.40	5.56	5.74
Market Cap	41.50M	102.71M	48.70M	53.41M	46.06M	50.05M	70.49M	74.43M	62.41M	78.31M	58.93M	74.34M
Enterprise Value	32.45M	92.36M	37.07M	40.13M	31.06M	48.65M	67.40M	69.28M	55.77M	69.79M	47.68M	60.17M
Calculated Values
Free Cash Flow TTM	-5.84M	-5.93M	-6.35M	-6.75M	-6.65M	-7.05M	-8.09M	-8.89M	-9.58M	-10.38M	-9.68M	-8.83M
Net Debt	-9.04M	-10.35M	-11.63M	-13.28M	-15.00M	-1.40M	-3.09M	-5.15M	-6.64M	-8.52M	-11.25M	-14.16M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-12-23Purchase

Owner: English, Aron R., 22Nw Fu…

Title: -

Shares: 10,101,010

Price/Share: $0.99

Value: $9,999,999.90

Shares Owned: 15,467,300

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-12-23	English, Aron R., 22Nw Fu…	TenPercentOwner	-	Indirect	Purchase	10,101,010	0.99	$9,999,999.90	15,467,300	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

54.06%

Inst. Shares: 22,208,686

Shares Outstanding: 41,084,731

2025-09-30

54.08%

Inst. Shares: 22,219,763

Shares Outstanding: 41,084,731

2025-06-30

66.80%

Inst. Shares: 22,591,946

Shares Outstanding: 33,820,306

2025-03-31

55.00%

Inst. Shares: 22,595,103

Shares Outstanding: 41,084,731

2024-12-31

82.33%

Inst. Shares: 22,570,347

Shares Outstanding: 27,415,430

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	22,208,686	41,084,731	54.06%
2025-09-30	22,219,763	41,084,731	54.08%
2025-06-30	22,591,946	33,820,306	66.80%
2025-03-31	22,595,103	41,084,731	55.00%
2024-12-31	22,570,347	27,415,430	82.33%
2024-09-30	22,031,202	25,933,217	84.95%
2024-06-30	21,923,334	25,822,258	84.90%
2024-03-31	21,919,095	25,933,217	84.52%
2023-12-31	21,836,973	25,789,739	84.67%
2023-09-30	21,151,473	25,633,217	82.52%
2023-06-30	21,095,649	25,074,481	84.13%
2023-03-31	73,780,314	25,633,217	287.83%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Anebulo Pharmaceuticals, Inc. (ANEB) — SEC Financial Statements & Analysis

Anebulo Pharmaceuticals, Inc. (ANEB) is a pharmaceutical preparations company, incorporated in DE. Anebulo Pharmaceuticals, Inc. trades on Nasdaq as: ANEB. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), Anebulo Pharmaceuticals, Inc. reported a Price-to-Book (P/B) ratio of 5.23 (TTM), at a market cap of $41.50M. Figures below are sourced from SEC EDGAR, as-filed.

P/B TTM: 5.23
Market Cap: $41.50M

Data as of 2025-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Anebulo Pharmaceuticals, Inc. in?

Anebulo Pharmaceuticals, Inc. (ANEB) operates in the Pharmaceutical Preparations industry.

What is ANEB's market cap?

Anebulo Pharmaceuticals, Inc. (ANEB) has a market capitalization of $41.50M as of 2025-12-31.

What exchange does ANEB trade on?

Anebulo Pharmaceuticals, Inc. (ANEB) trades on the Nasdaq.

Where is Anebulo Pharmaceuticals, Inc. incorporated?

Anebulo Pharmaceuticals, Inc. is incorporated in DE.

Anebulo Pharmaceuticals, Inc. (ANEB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.